| Name | Title | Contact Details |
|---|
Southwest Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Santa Rosa, CA. To find more information about Southwest Community Health Center, please visit www.swhealthcenter.org
COOK CHILDRENS HEALTH PLAN is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kalispell Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Kalispell Regional Medical Center is based in Kalispell, MT. You can find more information on Kalispell Regional Medical Center at www.krmc.org
Olympus delivers the world’s leading-edge nondestructive inspection and measurement solutions by developing tools and technologies that enhance safety, security, quality, and productivity. Our most popular offerings include ultrasound, phased array, microscopy, optical metrology, remote visual inspection, eddy current and XRF and XRD analyzers. We’re looking to share solutions, news, and insights about test, analytical, measurement, and imaging instruments with other industry professionals from the worlds of aerospace, power generation, petrochemical, manufacturing, automotive, consumer products, and many more.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.